Loading...
Back to narrative

HR: Share Buybacks And Earnings Outlook Will Shape A Measured Path Forward

HR: Modest Margin Gains And Earnings Outlook Will Guide Future Value

HR logo
HR
AnalystConsensusTarget
Not Invested
Published 20 Mar 2025

Update shared on 29 Nov 2025

Fair value Increased 1.04%
Previous
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-0.2%
7D
-1.3%

Healthcare Realty Trust’s average analyst price target has edged slightly higher from $19.30 to $19.50. Analysts attribute this change to modest adjustments in valuation assumptions and outlook.

What's in the News

  • Healthcare Realty Trust announced a share repurchase program, authorizing up to $500 million of outstanding shares to be repurchased through October 27, 2026. (Key Developments)
  • From July 1, 2025 to September 30, 2025, the company did not repurchase shares. The total buyback remains at 3,679,162 shares, or 1.03% of shares, valued at $63.04 million since the October 30, 2024 announcement. (Key Developments)
  • The company’s Board of Directors authorized a new buyback plan on October 28, 2025. (Key Developments)
  • Healthcare Realty Trust revised 2025 earnings guidance downward and now expects a loss per share between $0.86 and $0.81, compared to the previous forecast of $0.78 to $0.73. (Key Developments)

Valuation Changes

  • Consensus Analyst Price Target has risen slightly, from $19.30 to $19.50.
  • Discount Rate has increased marginally, moving from 8.15% to 8.18%.
  • Revenue Growth expectation has fallen slightly, from -0.58% to -0.62%.
  • Net Profit Margin estimate has decreased, dropping from 24.52% to 23.25%.
  • Future P/E ratio has risen, moving from 28.8x to 31.8x.

Have other thoughts on Healthcare Realty Trust?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.